bruce cree, md, phd, mas: the nmosd landscape after the inebilizumab approval
Published 4 years ago • 375 plays • Length 4:26Download video MP4
Download video MP3
Similar videos
-
4:15
bruce cree, md, phd, mas: the future landscape in nmosd
-
3:46
bruce cree, md, phd, mas: insights from the n-momentum study of inebilizumab
-
4:41
bruce cree, md, phd, mas: inebilizumab for nmosd treatment
-
3:10
bruce cree, md, phd, mas: inebilizumab in neuromyelitis optica spectrum disorder
-
3:55
bruce cree, md, phd, mas: exploring clinical utility of siponimod, fingolimod in ms
-
4:04
day-to-day care of nmosd, advances and challenges: bruce cree, md, phd, mas, faan
-
5:43
inebilizumab treatment in newly diagnosed nmosd patients
-
4:04
long term benefits of inebilizumab revealed in n momentum analysis
-
4:50
i am still the avery of the past | avery’s nmosd story
-
![what are hnpp and mctd? // my disabilities [cc]](https://i.ytimg.com/vi/cRHGjQlp9-I/mqdefault.jpg)
12:07
what are hnpp and mctd? // my disabilities [cc]
-
5:57
what does ms (multiple sclerosis) look like on brain mri? avoid wrongful diagnosis!
-
0:56
bruce cree – ectrims 2022
-
2:27
key considerations for clinicians treating nmosd
-
3:35
the payer dilemma with accessing effective therapies for nmosd
-
2:00
bruce cree, md, phd: long-term data collection in ms studies
-
1:57
which clinician usually diagnoses neuromyelitis optica spectrum disorder?
-
57:39
advances in s1pr modulation: progress in understanding brain atrophy and cognition measures in ms
-
4:41
challenges and potential of btk inhibitors in ms treatment
-
4:38
inebilizumab as a potential therapy for autoimmune encephalitis
-
2:16
bruce cree, md, phd: brain volume loss and disability progression in ms
-
4:34
updates on radius-r & radius-p: elezanumab for patients with relapsing and progressive forms of ms
-
2:41
multiple sclerosis - bruce a. cree, md